On the involvement of calpains in the degradation of the tumor suppressor protein p53

被引:69
|
作者
Gonen, H
Shkedy, D
Barnoy, S
Kosower, NS
Ciechanover, A
机构
[1] TECHNION ISRAEL INST TECHNOL,DEPT BIOCHEM,IL-31096 HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,RAPPAPORT FAMILY INST RES MED SCI,FAC MED,IL-31096 HAIFA,ISRAEL
[3] TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL
关键词
calpain; p53; ubiquitin; proteolysis;
D O I
10.1016/S0014-5793(97)00225-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A crude fraction that contains ubiquitin-protein ligases contains also a proteolytic activity of similar to 100 kDa that cleaves p53 to several fragments. The protease does not require ATP and is inhibited in the crude extract by an endogenous similar to 250 kDa inhibitor. The proteinase can be inhibited by chelating the Ca2+ ions, by specific cysteine proteinase inhibitors and by peptide aldehyde derivatives that inhibit calpains. Purified calpain demonstrates an identical activity that can be inhibited by calpastatin, the specific protein inhibitor of the enzyme. Thus, it appears that the activity we have identified in the extract is catalyzed by calpain. The calpain in the extract degrades also N-myc, c-Fos and c-Jun, but not lysozyme. In crude extract, the calpain activity can be demonstrated only when the molar ratio of the calpain exceeds that of its native inhibitor. Recent experimental evidence implicates both the ubiquitin proteasome pathway and calpain in the degradation of the tumor suppressor, and it was proposed that the two pathways may play a role in targeting the protein under various conditions. The potential role of the two systems in this important metabolic process is discussed. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [31] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [32] The p53 tumour suppressor protein
    Hickman, ES
    Helin, K
    BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL 17, 2000, 17 : 179 - 211
  • [33] Peptide and protein chemistry approaches to study the tumor suppressor protein p53
    Chatterjee, Champak
    Singh, Sumeet K.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2022, 20 (28) : 5500 - 5509
  • [34] The p53 tumour suppressor protein
    Hickman, E.S.
    Helin, K.
    Biotechnology and Genetic Engineering Reviews, 2000, 17 : 179 - 211
  • [35] Clinical applications of detecting dysfunctional p53 tumor suppressor protein
    Baas, IO
    Hruban, RH
    Offerhaus, GJA
    HISTOLOGY AND HISTOPATHOLOGY, 1999, 14 (01) : 279 - 284
  • [36] Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor
    Tripathi, Vivek
    Kaur, Ekjot
    Kharat, Suhas Sampat
    Hussain, Mansoor
    Damodaran, Arun Prasath
    Kulshrestha, Swati
    Sengupta, Sagar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (36) : 13224 - 13232
  • [37] ALTERED P53 TUMOR SUPPRESSOR GENE PROTEIN IN ACTINIC KERATOSIS
    ZIEGLER, A
    MARKS, R
    SHAPIRO, PE
    LEFFELL, DJ
    BRASH, DE
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 660 - 660
  • [38] p53 tumor suppressor protein overexpression in osteogenic tumors of dogs
    Sagartz, JE
    Bodley, WL
    Gamblin, RM
    Couto, CG
    Tierney, LA
    Capen, CC
    VETERINARY PATHOLOGY, 1996, 33 (02) : 213 - 221
  • [39] POSTTRANSLATIONAL REGULATION OF P53 TUMOR-SUPPRESSOR PROTEIN FUNCTION
    MAXWELL, SA
    ROTH, JA
    CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (01): : 23 - 57
  • [40] THE P53 TUMOR SUPPRESSOR PROTEIN, A MODULATOR OF CELL-PROLIFERATION
    ULLRICH, SJ
    ANDERSON, CW
    MERCER, WE
    APPELLA, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (22) : 15259 - 15262